an itemprop="name">John Castellani , president and CEO of Pharmaceutical Research and Manufacturers of America, will offer his perspective on trends in the industry as the symposium's keynote speaker. Castellani leads the trade association, known familiarly as PhRMA, that represents the nation's major pharmaceutical research and biotechnology companies.
The symposium will delve into some of the industry's most pressing issues, including the latest innovations to make clinical trials more cost efficient, the progress of FDA efforts to expedite the development of "breakthrough'' drugs, regulatory crackdowns on the manufacturing of injectable medicines and the status of efforts to supply the nation with new anti-infectives.
Sherman is also expected to provide an update on the widely anticipated introduction of biosimilars, new, slightly modified versions of existing biologic medicines that include many powerful cancer-fighters.
The medicines, which have been available in Europe for nearly five years, were expected to provide U.S. patients with alternatives to the high-priced biologics and to help major pharmaceutical companies boost revenues.
"The agency is committed to moving the science forward as soon as possible," Sherman said in an interview leading up to the symposium, "but to date, the FDA has not received an application."
There are no indications that regulators will be reviewing one of the new medicines within the next 10 months. The progress of their development, Sherman said, sits with the drug makers.
"We are doing everything we can," she said, "not to be the stumbling block, by providing for a clear and transparent pathway."
Rutgers Business School offers one of the top-rated MBA programs in
Page: 1 2 3 Related medicine technology :1
|SOURCE Rutgers Business School|
Copyright©2012 PR Newswire.
All rights reserved
. High Return-on-Investment Fueling Demand For Rutgers MBA Program2
. Rutgers Business Schools Pharma Industry Scholars Program offers students distinct advantages to help boost careers in healthcare industry3
. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade4
. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million5
. Nominations Open for San Francisco Business Times Health Care Heroes Awards6
. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association7
. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance8
. eCardios CEO to Speak During "Act at the Speed of Opportunity" Event Presented by Comcast Business Class and Inc.9
. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development10
. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update11
. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students